Kewalramani Reshma's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Dec 19, 2023
- Accession no.
- 0000875320-23-000062
- Filed
- Dec 19, 2023
- Trade date
- Dec 15, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.97M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kewalramani ReshmaCIK 0001735944 | Director, Officer (CEO & President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2023 | Common Stock | MOption exerciseAcquired | +3,058 | $155.57 | +$475,733.06 | 111,769 | Direct | |
| Dec 15, 2023 | Common Stock | MOption exerciseAcquired | +14,077 | $187.53 | +$2,639,859.81 | 125,846 | Direct | |
| Dec 15, 2023 | Common Stock | SSaleDisposed | −17,135 | $407.00 | −$6,973,945 | 108,711 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2023 | Common Stock | MOption exerciseDisposed | −3,058 | $0.00 | $0 | 0 | Direct | |
| Dec 15, 2023 | Common Stock | MOption exerciseDisposed | −14,077 | $0.00 | $0 | 1,565 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.